Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 16.78B | 15.22B | 12.55B | 12.62B | 10.88B | 8.60B |
Gross Profit | 5.69B | 5.14B | 4.08B | 4.03B | 3.40B | 2.66B |
EBITDA | 4.26B | 3.80B | 3.00B | 2.99B | 2.50B | 1.95B |
Net Income | 2.61B | 2.42B | 1.93B | 1.90B | 1.59B | 1.20B |
Balance Sheet | ||||||
Total Assets | 22.90B | 21.44B | 16.53B | 15.33B | 14.68B | 12.33B |
Cash, Cash Equivalents and Short-Term Investments | 1.67B | 3.34B | 1.66B | 1.43B | 1.24B | 1.74B |
Total Debt | 7.17B | 6.89B | 4.34B | 4.58B | 4.80B | 3.87B |
Total Liabilities | 12.53B | 11.58B | 8.10B | 8.23B | 8.30B | 6.88B |
Stockholders Equity | 10.30B | 9.79B | 8.35B | 7.02B | 6.30B | 5.38B |
Cash Flow | ||||||
Free Cash Flow | 2.22B | 2.15B | 2.16B | 1.79B | 1.18B | 1.32B |
Operating Cash Flow | 2.98B | 2.81B | 2.53B | 2.17B | 1.54B | 1.59B |
Investing Cash Flow | -4.98B | -2.65B | -1.39B | -731.10M | -1.89B | -333.50M |
Financing Cash Flow | 1.81B | 1.73B | -1.01B | -1.20B | -145.20M | -516.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $39.19B | 26.81 | 19.04% | 1.77% | 18.08% | 7.28% | |
78 Outperform | $49.78B | 36.49 | 11.33% | 1.69% | 1.23% | -58.22% | |
78 Outperform | $28.25B | 38.55 | 14.30% | ― | -1.16% | -7.04% | |
77 Outperform | $117.36B | 46.42 | 27.53% | 0.68% | 30.70% | 27.09% | |
75 Outperform | $23.82B | 31.03 | 7.70% | 0.46% | 0.85% | -10.01% | |
64 Neutral | $44.01B | 98.39 | 4.14% | 2.18% | 9.77% | -26.50% | |
63 Neutral | $32.90B | 6.03 | -11.70% | 1.95% | 5.55% | -19.87% |
On June 16, 2025, Amphenol Corporation issued €600 million in 3.125% Senior Notes due 2032, following a public offering managed by several financial institutions. The proceeds from this issuance, along with those from a prior offering of $750 million in 4.375% Senior Notes due 2028, are intended to repay borrowings under Amphenol’s U.S. commercial paper program and for general corporate purposes, potentially impacting the company’s financial strategy and market positioning.
The most recent analyst rating on (APH) stock is a Buy with a $82.00 price target. To see the full list of analyst forecasts on Amphenol stock, see the APH Stock Forecast page.
On June 12, 2025, Amphenol Corporation issued $750 million in 4.375% Senior Notes due 2028 through an underwritten public offering. The company also announced the pricing of €600 million in 3.125% Senior Notes due 2032, with the closing expected on June 16, 2025. The proceeds from these offerings will be used to repay borrowings under Amphenol’s U.S. commercial paper program and for general corporate purposes. The issuance of these notes is part of Amphenol’s strategy to manage its debt and financial operations efficiently.
The most recent analyst rating on (APH) stock is a Buy with a $82.00 price target. To see the full list of analyst forecasts on Amphenol stock, see the APH Stock Forecast page.
On June 11, 2025, Amphenol Corporation announced the pricing of its €600 million senior notes due 2032, with an interest rate of 3.125% per annum. The closing of this Euro Notes offering is anticipated on June 16, 2025, and the proceeds will be used to repay borrowings and for general corporate purposes. Additionally, on June 9, 2025, Amphenol announced the pricing of $750 million senior notes due 2028, with a 4.375% interest rate, expected to close on June 12, 2025. These offerings are not contingent upon each other, highlighting Amphenol’s strategic financial maneuvers to strengthen its capital structure.
The most recent analyst rating on (APH) stock is a Buy with a $82.00 price target. To see the full list of analyst forecasts on Amphenol stock, see the APH Stock Forecast page.
On June 9, 2025, Amphenol Corporation announced the pricing of its $750 million senior notes due 2028, with an interest rate of 4.375% per annum. The offering is expected to close on June 12, 2025, subject to customary conditions. The company plans to use the proceeds to repay borrowings under its U.S. commercial paper program and for general corporate purposes. Additionally, Amphenol may offer euro-denominated notes, although the completion of one offering is not contingent on the other. This strategic financial move aims to strengthen Amphenol’s financial flexibility and support its operations across various high-growth markets.
The most recent analyst rating on (APH) stock is a Buy with a $82.00 price target. To see the full list of analyst forecasts on Amphenol stock, see the APH Stock Forecast page.
On May 15, 2025, Amphenol Corporation’s stockholders approved an amendment to increase the number of authorized shares of Class A Common Stock from 2 billion to 5 billion. This amendment became effective upon filing with the Secretary of State of Delaware on the same day. During the annual meeting, stockholders also elected directors, ratified Deloitte & Touche LLP as independent accountants, approved executive compensation, and rejected a proposal for special shareholder meeting improvements.
The most recent analyst rating on (APH) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on Amphenol stock, see the APH Stock Forecast page.
On May 8, 2025, Amphenol Corporation appointed Michael R. Ivas as the principal accounting officer, succeeding Craig A. Lampo, who remains the Chief Financial Officer. Mr. Ivas, who has been with the company since 2001, brings extensive experience from his previous roles within Amphenol and his earlier career at PricewaterhouseCoopers, enhancing the company’s financial leadership.
The most recent analyst rating on (APH) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on Amphenol stock, see the APH Stock Forecast page.